ORIC Pharmaceuticals
Phase 1Overcoming resistance
Founded
2014
Focus
Small Molecules
About
Overcoming resistance
Funding History
4Total raised: $282M
IPO$120MUndisclosedJan 31, 2020
Series C$55MForesite CapitalMar 15, 2019
Series B$50MThe Column GroupJun 15, 2017
Series A$57MThe Column GroupDec 15, 2014
Company Info
TypePrivate
Founded2014
LocationSouth San Francisco, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile